How it works
Tesamorelin is a stabilized growth-hormone-releasing hormone (GHRH) analog that stimulates the pituitary to release growth hormone. In clinical research it has been reported to reduce visceral (abdominal) fat and to affect IGF-1 levels and lipid profiles in study populations.
For laboratory and research use only — not for human or veterinary consumption.
Tesamorelin — Lyophilized Powder | For Research Use Only
Tesamorelin is a synthetic GHRH analog peptide supplied as a research-grade reference compound for in vitro and preclinical laboratory study.
Compound profile
A modified analog of GHRH(1–44) with a trans-3-hexenoyl group at the N-terminus to enhance metabolic stability. Used in laboratory research models examining GHRH receptor pharmacology, somatotroph signaling, and IGF-1 pathway assays.
Specifications
Form: lyophilized powder (sterile, aseptic fill). Purity: ≥99% by HPLC. Endotoxin testing: LAL method, batch-certified. Identity confirmed by mass spectrometry. Certificate of Analysis available per lot.
Storage & handling
Lyophilized vials: store at -20°C for long-term stability; 2–8°C acceptable short-term. Protect from UV light and humidity. Once reconstituted with bacteriostatic water, store at 2–8°C and utilize within 28–30 days. Avoid repeated freeze-thaw cycles.
Regulatory notice
This product is supplied strictly for in vitro and preclinical laboratory research by qualified personnel. It has not been evaluated by the FDA or any equivalent regulatory authority. It is not approved for, nor intended for, human or veterinary use, clinical administration, or dietary supplementation. Not for resale or use outside of a controlled research environment.
Tesamorelin – Research Peptide
Research Kit – 20% off 10+ vials (full box)